Discover Opportunities months before the RFP drops
Learn more →The Department of State (Bureau of Diplomatic Security) issued Solicitation 19AQMM25R0222 for local guard services at the U.S. Mission in Freetown, Sierra Leone. Access to the full solicitation is restricted and requires submission of a Restricted Access Request form; a draft PWS and related materials are referenced in the posting. The opportunity is a competitive, full & open solicitation (NAICS 561612, PSC S206) administered by the DOS Office of Acquisition Management.
Posted Date
Sep 15, 2025
Due Date
Dec 20, 2025
Release: Sep 15, 2025
Close: Dec 20, 2025
The Department of State (Bureau of Diplomatic Security) issued Solicitation 19AQMM25R0222 for local guard services at the U.S. Mission in Freetown, Sierra Leone. Access to the full solicitation is restricted and requires submission of a Restricted Access Request form; a draft PWS and related materials are referenced in the posting. The opportunity is a competitive, full & open solicitation (NAICS 561612, PSC S206) administered by the DOS Office of Acquisition Management.
AvailableTo support the continuation of the vaccine mcms for pandemic influenza preparedness and response program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (u. S. Facilities preferred) not otherwise provided by the usg as needed to provide mcms, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by barda; produce antigens, adjuvants, and/or vaccines to support usg efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to fda all relevant data (e. G. , analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (cmc)), including data generated during interpandemic periods.
Posted Date
Nov 7, 2025
Due Date
Dec 19, 2025
Release: Nov 7, 2025
Close: Dec 19, 2025
To support the continuation of the vaccine mcms for pandemic influenza preparedness and response program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (u. S. Facilities preferred) not otherwise provided by the usg as needed to provide mcms, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by barda; produce antigens, adjuvants, and/or vaccines to support usg efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to fda all relevant data (e. G. , analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (cmc)), including data generated during interpandemic periods.
AvailableTo support the advanced development, clinical evaluation, and FDA clearance of mNGS-based diagnostic assays for viral and bacterial pathogen detection. BARDA seeks highly flexible, rapidly adaptable systems capable of identifying all known viral and bacterial pathogens within a given specimen (e.g., respiratory sample) and reconfiguring-through database or software updates—to detect emerging pathogens during public health emergencies. BARDA requires the use of existing mNGS-based sequencing platforms or mNGS platforms that are already in development.
Posted Date
Oct 23, 2025
Due Date
Nov 20, 2025
Release: Oct 23, 2025
Close: Nov 20, 2025
To support the advanced development, clinical evaluation, and FDA clearance of mNGS-based diagnostic assays for viral and bacterial pathogen detection. BARDA seeks highly flexible, rapidly adaptable systems capable of identifying all known viral and bacterial pathogens within a given specimen (e.g., respiratory sample) and reconfiguring-through database or software updates—to detect emerging pathogens during public health emergencies. BARDA requires the use of existing mNGS-based sequencing platforms or mNGS platforms that are already in development.
More RFPs available with Premium →
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis